Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
NUMA1
REST API REST API
Homo sapiens
NUMA1 is differentially expressed in 345 experiments: 150 organism parts: prostate, liver, ... (148 more);, 208 disease states: normal, prostate carcinoma, ... (206 more);, 104 cell types 413 cell lines 47 compound treatments and 87 other conditions.
Orthologs F1LW91_RAT (Rattus norvegicus)   USO1 (Saccharomyces cerevisiae)   NUMA1 (Bos taurus)   ENSCING00000003507 (Ciona intestinalis)   NUMA1 (Gallus gallus)   ENSCING00000016582 (Ciona intestinalis)   Numa1 (Mus musculus)   ENSCING00000008718 (Ciona intestinalis)   cp309 (Drosophila melanogaster)   numa1 (Xenopus laevis)   NUMA1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, establishment of mitotic spindle orientation, spindle pole, protein binding, mitotic cell cycle, structural molecule activity, spindle microtubule, spindle, nucleus organization, nucleus, G2/M transition of mitotic cell cycle, apical part of cell, chromosome, nucleoplasm, mitotic anaphase, lung epithelial cell differentiation
UniProt Accession Q96HN5, Q9UPG3, Q9UNL7, Q86XH4, Q4LE64, Q14980, Q9BTE9, Q59HB8, F5GZW1, F5H7R5, F5GWA2, F5GWK2, F5H2L0, F5H2F3, F5H1L0, F5H0Z7, F5H073, F5H068, F5H6Y5, F5H763, F5H4Y4, F5H4J1, F5H3L6, F8W6T3
Search EB-eye ENSG00000137497
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-17189, E-GEOD-803, E-GEOD-15765, E-GEOD-22541, E-GEOD-6573, ... (32 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, E-GEOD-18005, ... (45 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-20081, E-GEOD-19639, E-GEOD-3529, E-GEOD-5823
BT474
3
E-MTAB-62, E-MEXP-440, E-MTAB-37
BT-474
2
E-GEOD-3529, E-GEOD-5823
A549
2
E-GEOD-6013, E-GEOD-3202
LNCaP
2
E-GEOD-14990, E-GEOD-14464
MCF-10A
2
E-TABM-420, E-GEOD-14990
407 more value(s).


Cell type

studied in E-GEOD-22529, E-GEOD-21668, E-GEOD-3920, E-MEXP-750, E-GEOD-4219, ... (47 experiments)

Factor Value U/D Experiments
CD8+ T cell
2
E-AFMX-5, E-TABM-145
fibroblast
2
E-GEOD-3920, E-GEOD-3204
plasmablast
1
E-MEXP-2360
basal cell
1
E-GEOD-3998
activated natural killer cell (supplemented for IL2 for 8 hours)
1
E-TABM-702
monocyte at intermediate differentiation stage
1
E-GEOD-5099
98 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-MEXP-1121, E-GEOD-1577, ... (71 experiments)

Factor Value U/D Experiments
prostate carcinoma
4
E-GEOD-96, E-MTAB-62, E-MEXP-2034, E-GEOD-7307
Huntington's disease
2
E-AFMX-6, E-GEOD-3790
glioblastoma
2
E-GEOD-4412, E-GEOD-6014
Burkitt's lymphoma
2
E-MTAB-37, E-GEOD-1880
adrenocortical carcinoma
2
E-TABM-311, E-GEOD-10927
choriocarcinoma
2
E-MTAB-37, E-MTAB-62
202 more value(s).


Compound treatment

studied in E-GEOD-1615, E-GEOD-4668, E-GEOD-5258, E-GEOD-1417, E-GEOD-3720, ... (29 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-GEOD-3720, E-MEXP-1958
4-hydroxytamoxifen
2
1
E-MEXP-2241
ethanol
1
E-MEXP-2241
valproic acid
1
E-GEOD-1615
5-aza-2'-deoxycytidine + trichostatin A
2
1
E-MEXP-1269
cigarette smoke
1
E-TABM-127
41 more value(s).


Age at diagnosis

studied in E-GEOD-21653

Factor Value U/D Experiments
28
2
1
E-GEOD-21653


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd4
studied in E-GEOD-22601

cd8
studied in E-GEOD-22601

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-TABM-125, ... (8 experiments)

Clinical history age
studied in E-TABM-118

Clinical history extra intestinal
studied in E-TABM-118

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-17189, E-GEOD-6710, E-MEXP-1251, ... (9 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-1614, E-GEOD-20033, E-GEOD-3140, E-MEXP-2359, E-GEOD-6236, ... (7 experiments)

Dfs follow up
studied in E-GEOD-22541

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-GEOD-3325, E-GEOD-22541, E-TABM-147, ... (7 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1518, E-GEOD-3720

Epiregulin elisa conc ng ml
studied in E-GEOD-5851

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-GEOD-7011, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, ... (6 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-17476, E-GEOD-2466, E-GEOD-22593, E-TABM-868, ... (16 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-7011, E-GEOD-10315, E-TABM-440, E-GEOD-837, ... (15 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-16194, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-5764, E-TABM-740, E-GEOD-2466, ... (45 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-GEOD-12254, E-MEXP-561, ... (6 experiments)

Injury
studied in E-GEOD-19743

Irradiate
studied in E-GEOD-1977

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Localisation of metastases
studied in E-GEOD-22541

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

Organism
studied in E-GEOD-1801, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-19703, E-GEOD-1309, E-GEOD-21750, E-GEOD-6434, E-GEOD-1657, ... (8 experiments)

Population
studied in E-MTAB-197, E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, ... (6 experiments)

Replicate
studied in E-GEOD-18791

Rna integrity
studied in E-TABM-325

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-MEXP-101, E-GEOD-3697, E-MEXP-1857, ... (7 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-17400, E-GEOD-18995

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-2508, E-GEOD-19069, E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996, E-TABM-125

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276

Transfection
studied in E-GEOD-14680

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-GEOD-16837, E-MEXP-973, E-GEOD-21909, ... (9 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-GEOD-3494, E-GEOD-22541, E-GEOD-1561, ... (8 experiments)

Tumor size
studied in E-GEOD-6532, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.365 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM